Coty Inc. — FY2016 Form 10-K Summary
Reporting period: Fiscal year ended June 30, 2016. This is an annual filing, not a standalone Q4 report; quarterly figures are included in the filing. All amounts are U.S. dollars unless noted.
Business context
Coty is a global beauty company selling fragrances, color cosmetics, skin and body care, and, following its February 2016 acquisition, personal care and beauty products in Brazil. Products are sold in more than 130 countries across prestige and mass channels. Fiscal 2016 revenue mix was approximately 46% fragrances, 36% color cosmetics, 16% skin and body care, and 2% Brazil Acquisition.
Key financial metrics
| Metric | FY2016 | FY2015 | Change |
|---|---|---|---|
| Net revenues | $4,349.1 million | $4,395.2 million | Down 1% |
| Gross profit | $2,603.1 million | $2,638.2 million | Down 1% |
| Gross margin | 59.9% | 60.0% | Down about 10 bps |
| Operating income | $254.2 million | $395.1 million | Down 36% |
| Operating margin | 5.8% | 9.0% | Down about 320 bps |
| Net income attributable to Coty | $156.9 million | $232.5 million | Down 33% |
| Diluted GAAP EPS | $0.44 | $0.64 | Down 31% |
| Adjusted operating income (non-GAAP) | $622.9 million | $603.6 million | Up 3% |
| Adjusted operating margin (non-GAAP) | 14.3% | 13.7% | Up about 60 bps |
| Adjusted net income attributable to Coty (non-GAAP) | $485.2 million | $408.5 million | Up 19% |
| Operating cash flow | $501.4 million | $526.3 million | Down $24.9 million |
| Investing cash flow | $(1,059.2) million | $(171.2) million | Higher outflow, mainly acquisition-related |
| Cash and cash equivalents | $372.4 million | $341.3 million | Up $31.1 million |
| Total debt | $4,170.1 million | $2,634.7 million | Up $1,535.4 million |
At year-end, current assets were $1,938.4 million and current liabilities were $1,855.2 million. Cash was substantially held outside the U.S.: foreign operations held $364.8 million, or 98% of total cash. Coty reported compliance with its debt covenants at June 30, 2016.
Material changes versus FY2015
- Revenue declined despite 13% reported unit-volume growth: negative price and mix of 9% and currency translation of 5% more than offset volume. Excluding acquisitions, divestitures, specified discontinued operations and currency, revenue decreased 1%.
- Fragrances revenue fell 8% to $2,012.7 million; segment operating income fell 18% to $288.9 million. Management cited weak mass-fragrance trends, mature product lines, lower launch activity and currency effects.
- Color Cosmetics revenue rose 7% to $1,547.5 million, largely reflecting Bourjois; excluding Bourjois and currency, segment revenue decreased 3%. Segment operating income increased 35% to $213.7 million.
- Skin & Body Care revenue declined 10% to $693.4 million; operating income was $39.3 million, versus $33.1 million in FY2015. Brazil contributed $95.5 million of revenue and $1.5 million of operating income after its February acquisition.
- Operating income fell mainly because acquisition-related costs increased to $174.0 million from $34.1 million, alongside higher restructuring costs. FY2016 also included a $24.8 million gain on sale of the Cutex brand and $5.5 million of impairment charges.
- Cash flow from investing included $908.7 million of net payments for business combinations. Coty paid $901.9 million for the Brazil business. Debt refinancing and additional borrowing materially increased reported debt.
Outlook, commentary and risks
- P&G transaction: Coty expected to complete the acquisition of P&G’s beauty businesses in October 2016, subject to regulatory clearances, works council consultations and other conditions. The proposed combination was expected to produce approximately $9.2 billion in annual revenue based on FY2015 performance, with Coty projecting $780 million of cost savings over four fiscal years.
- Coty estimated approximately $1.2 billion of operating expenses and $500 million of capital expenditures associated with the transaction through FY2020. Failure to complete the transaction could leave approximately $400 million of costs unrecoverable as of June 30, 2016. These are company estimates, not guaranteed outcomes.
- Following the transaction, Coty planned to reorganize into luxury, consumer beauty and professional beauty divisions, and to divest or discontinue brands representing 6%–8% of combined-company revenue. The filing describes these plans but does not provide formal standalone FY2017 earnings or revenue guidance.
- Management cited challenging mass-fragrance markets, declining mature brands, foreign-exchange exposure, retailer and distributor risks, and the execution demands of acquisition integration. The filing also highlights potential impairment, product-safety, supply-chain, licensing, cyber and international regulatory risks.
- Contingency: A U.S. antiboycott compliance review remained open. Coty said a material penalty was reasonably possible, had not recorded a reserve, and could not estimate any penalty. The investigation’s statute of limitations was extended to November 30, 2016. Separate export-control and sanctions matters had previously been closed by authorities without financial penalties.
- Unusual tax item: FY2016 included a tax benefit associated with settlement of IRS audits and expiration of statutes of limitation; the reported effective tax rate was a benefit of 29.1%. GAAP and adjusted results therefore differ substantially, and adjusted measures exclude specified costs and other items.
- In August 2016, after year-end, the Board raised the annual dividend to $0.275 per share from $0.25. The filing states Coty intended to increase it to $0.50 after completion of the P&G transaction; that intention was conditional, not a completed action.
Most important facts for investors to verify
- Whether the P&G transaction closed on the anticipated terms and timeline, including final assumed debt, share issuance, integration costs and realized synergies.
- Whether acquisition and restructuring expenditures, including the estimated $1.2 billion of operating expenses and $500 million of capital expenditures, differ from management’s estimates.
- Whether revenue trends in fragrances and skin and body care stabilize, and whether color cosmetics growth persists after separating Bourjois and currency effects.
- Whether Coty sustains operating cash generation while servicing substantially higher debt, and remains within its financial covenants.
- The outcome and any financial or reputational effects of the open antiboycott investigation, and any other material legal or tax contingencies.
- Whether the stated dividend increase and planned post-transaction dividend are implemented, taking account of debt covenants and transaction restrictions.